/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Reviva Pharmaceuticals Holdings Share Price Today: Live Updates & Key Insights

Reviva Pharmaceuticals Holdings share price today is $0.795, up -4.01%. The stock opened at $0.84 against the previous close of $0.8334, with an intraday high of $0.9323 and low of $0.7901.

Reviva Pharmaceuticals Holdings Share Price Chart

style
pb-0

Reviva Pharmaceuticals Holdings

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Reviva Pharmaceuticals Holdings Share Price Performance

$0.795 -0.0401(-4.01%) RVPH at 23 Mar 2026 03:05 PM Biotechnology
Lowest Today 0.7901
Highest Today 0.9323
Today’s Open 0.84
Prev. Close 0.8334
52 Week High 23.40
52 Week Low 0.67
Day’s Range: Low 0.7901 High 0.9323
52-Week Range: Low 0.67 High 23.40
1 day return -
1 Week return -69.01
1 month return +229.34
3 month return +32.76
6 month return +157.02
1 year return -26.84
3 year return -79.94
5 year return -88.79
10 year return -

Reviva Pharmaceuticals Holdings Institutional Holdings

Vanguard Group Inc 2.74

Diadema Partners LP 2.15

Millennium Management LLC 1.94

Vanguard Total Stock Mkt Idx Inv 1.02

Vanguard Institutional Extnd Mkt Idx Tr 0.99

Geode Capital Management, LLC 0.90

Jane Street Group LLC 0.77

Susquehanna International Group, LLP 0.58

Citadel Advisors Llc 0.47

Fidelity Extended Market Index 0.47

Blackrock Extended Mkt Fund CF 0.32

Abante Quant Value FI 0.30

Extended Equity Market Fund K 0.27

Fidelity Total Market Index 0.19

NT Ext Equity Mkt Idx Fd - L 0.16

SIMPLEX TRADING, LLC 0.15

Spartan Extended Market Index Pool F 0.15

Fidelity Series Total Market Index 0.11

EMC Capital Management(TX) 0.11

State Street Corp 0.11

Vanguard Instl Ttl Stck Mkt Idx Tr 0.09

XTX Topco Ltd 0.09

Lido Advisors, LLC 0.08

Spartan Total Market Index Pool G 0.07

Vanguard Instl Ttl Stk Mkt Idx InstlPls 0.07

Vanguard Balanced Index Inv 0.06

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.06

Northern Trust Corp 0.06

Group One Trading, LP 0.05

Vanguard U.S. Eq Idx £ Acc 0.05

BlackRock Inc 0.05

The Colony Group LLC 0.05

Northern Trust Extended Eq Market Idx 0.04

Commonwealth Equity Services Inc 0.03

Extended Equity Market Fund M 0.03

Cutler Investment Counsel, LLC 0.03

Becker Capital 0.03

Creative Planning Inc 0.03

NT Ext Equity Mkt Idx Fd - NL 0.02

Fidelity Nasdaq Composite Index 0.02

Reviva Pharmaceuticals Holdings Market Status

Strong Buy: 3

Buy: 3

Hold: 0

Sell: 0

Strong Sell: 0

Reviva Pharmaceuticals Holdings Fundamentals

Market Cap 4.70 M

PB Ratio 1.0273

PE Ratio 0.0

Enterprise Value -5.58 M

Total Assets 15.50 M

Volume 1978983

Reviva Pharmaceuticals Holdings Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:-724740 -0.7M, FY19:null 0.0M

Annual Net worth FY23:-37654706 -37.7M, FY22:-24339292 -24.3M, FY21:-8521876 -8.5M, FY20:-3783388 -3.8M, FY19:-846832 -0.8M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:null 0.0M, Q1/2025:null 0.0M, Q3/2024:null 0.0M, Q2/2024:null 0.0M

Quarterly Net worth Q3/2025:-4010773 -4.0M, Q2/2025:-6053610 -6.1M, Q1/2025:-6432840 -6.4M, Q3/2024:-8365798 -8.4M, Q2/2024:-7859919 -7.9M

About Reviva Pharmaceuticals Holdings & investment objective

Company Information Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer's disease, and Parkinson's disease psychosis; in clinical development for respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis; and in preclinical development for the treatment of psoriasis. It is also developing RP1208 for the treatment of depression and obesity. The company was founded in 2018 and is headquartered in Cupertino, California.

Organisation Biotechnology

Employees 14

Industry Biotechnology

CEO Dr. Laxminarayan Bhat Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

Reviva Pharmaceuticals Holdings FAQs

What is the share price of Reviva Pharmaceuticals Holdings today?

The current share price of Reviva Pharmaceuticals Holdings is $0.795.

Can I buy Reviva Pharmaceuticals Holdings shares in India?

Yes, Indian investors can buy Reviva Pharmaceuticals Holdings shares by opening an international trading and demat account with Motilal Oswal.

How to buy Reviva Pharmaceuticals Holdings shares in India?

You can easily invest in Reviva Pharmaceuticals Holdings shares from India by:

Can I buy fractional shares of Reviva Pharmaceuticals Holdings?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Reviva Pharmaceuticals Holdings?

Reviva Pharmaceuticals Holdings has a market cap of $4.70 M.

In which sector does Reviva Pharmaceuticals Holdings belong?

Reviva Pharmaceuticals Holdings operates in the Biotechnology sector.

What documents are required to invest in Reviva Pharmaceuticals Holdings stocks?

To invest, you typically need:

What is the PE and PB ratio of Reviva Pharmaceuticals Holdings?

The PE ratio of Reviva Pharmaceuticals Holdings is N/A and the PB ratio is 1.03.